山东大学耳鼻喉眼学报 ›› 2014, Vol. 28 ›› Issue (6): 72-76.doi: 10.6040/j.issn.1673-3770.0.2014.114

• 论著 • 上一篇    下一篇

2型糖尿病患者超声乳化白内障摘除并人工晶体植入手术后黄斑区光学相干断层扫描改变

孙洪义, 张晗   

  1. 山东大学第二医院眼科, 山东 济南 250033
  • 收稿日期:2014-04-12 发布日期:2014-12-16
  • 通讯作者: 张晗,主任医师,教授. E-mail:zhanghan9157@gmail.com E-mail:zhanghan9157@gmail.com
  • 作者简介:孙洪义. E-mail:dr351@126.com

Changes of macular thickness under optical coherent tomography in type 2 diabetic patients with cataract after phacoemulsification surgery and IOL implantation

SUN Hong-yi, ZHANG Han   

  1. Department of Ophthalmology, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2014-04-12 Published:2014-12-16

摘要: 目的 观察超声乳化白内障摘除并人工晶体植入手术对2型糖尿病患者黄斑区组织结构的影响.方法 分析 84 例行超声乳化白内障摘除并人工晶体植入术的2型糖尿病患者的病历资料,手术眼与对侧未手术眼进行对照观察,以手术眼为观察组,对侧眼为对照组.分别于术前、术后1 d、7 d及30 d时,记录中心凹视网膜厚度(FRT)及黄斑区容积(PMV)的光学相干断层扫描(OCT)测量资料.结果 中心凹视网膜厚度(FRT):观察组和对照组手术前测量结果,差异无统计学意义(P>0.05);手术后1 d,观察组(258.06±23.34)μm,对照组(259.88±21.01)μm, P>0.05;术后7 d,观察组(270.94±20.26)μm,对照组(260.54±20.88)μm, P<0.05;术后30 d,观察组(275.46±25.38)μm,对照组(260.68±22.95μm), P<0.05.黄斑区容积(PMV):手术前两组间差异无统计学意义(P>0.05);手术后1 d,观察组(8.29±0.55)mm3,对照组(8.28±0.54)mm3, P>0.05;术后7 d,观察组(8.68±0.68)mm3,对照组(8.32±0.62)mm3, P<0.05;术后30 d,观察组(9.46±0.73)mm3,对照组(8.34±0.58)mm3, P<0.05.判定术后1个月内黄斑水肿新增/加重者观察组有15 只眼,对照组有2只眼.结论 2型糖尿病患者超声乳化白内障摘除并人工晶体植入术后黄斑水肿的发生率增加,水肿程度加重.

关键词: 白内障手术, 超声乳化, 黄斑水肿, 光学相干断层扫描, 糖尿病

Abstract: Objective To investigate the effects of phacoemulsification surgery and IOL implantation on the macular area in type 2 diabetic patients with cataract. Methods 84 type 2 diabetic patients with cataract underwent single-eye phacoemulsification operation were enrolled into the study. OCT (Optical coherent tomography) were performed before the operations, and 1 day, 7 days, 30 days after the operations in all 168 eyes. The 84 operated eyes were assigned to the study group, while the other 84 eyes were assigned to the control group. The FRT(foveal retina thickness) (at 1 mm) and PMV (perimacular volume) (at 6 mm) of the two groups were analyzed with SPSS 19.0. Results FRT: There was no significant difference between the two groups before the surgery(P>0.05), as well as 1day after the surgery (study group 258.06±23.34 μm, control group 259.88±21.01 μm; P>0.05). However, significant differences were noted at 7 days (study group 270.94±20.26 μm, control group 260.54±20.88 μm) and 30 days(study group 275.46±25.38 μm, control group 260.68±22.95 μm; both P<0.05) after the surgery. Similar changes also happened in PMV data: before and 1 day after the surgery(P<0.05), at 7 days (study group 8.68±0.68 mm3, control group 8.32±0.62 mm3; P<0.05), and 30 days (study group 9.46±0.73 mm3, control group 8.34±0.58 mm3; P<0.05). Macular edema occurred or aggravated in 15 eyes of the study group and 2 eyes of the control group. Conclusion There are more chances of macular edema or aggravation after phacoemulsification surgery and IOL implantation than without for type 2 diabetic patients.

Key words: Cataract surgery, Phacoemulsification, Optical coherent tomography, Diabetes mellitus, Macular edema

中图分类号: 

  • R776.1
[1] Wright P L, Wilkinson C P, Balyeat H D, et al. Angiographic cystoid macular edema after posterior chamber lens implantation[J]. Arch Ophthamol, 1988, 106(6):740-744.
[2] Kim S J, Equi R, Bressler N M. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography[J]. Ophthamology, 2007, 114(5):881-889.
[3] Virgili G, Menchini F, Murro V, et al. Optical coherence tomography for detection of macular oedema in patients with diabetic retinopathy[J]. Cochrane Database Syst Rev, 2011, 6(7):CD008081.
[4] 王晋瑛,高媛.糖尿病性白内障与老年性白内障行超声乳化术后视力分析[J]. 国际眼科杂志,2010,10(10):2014-2015. WANG Jinying, GAO Yuan. Visual analysis of phacoemulsification for diabetic cataract and senile cataract[J]. Inter J Ophthalmol, 2010, 10(10):2014-2015.
[5] 程冰,刘杏,刘奕志,等.糖尿病患者超声乳化白内障吸出术后黄斑改变的光学相干断层扫描[J]. 中华眼底病杂志,2001,17(3):175-177. CHENG Bing, LIU Xing, LIU Yizhi, et al. Phacoemulsification cataract extraction in patients with postoperative diabetic macular changes of optical coherence tomography[J]. Chin J Ocular Fundus Dis, 2001, 17(3):175-177.
[6] Tu Y, Xu L, Wei W B, et al. Progression of diabetic retinopathy: the Beijing Eye Study[J]. Chin Med J (Engl), 2011, 124(22):3635-3640.
[7] 孙倩,廖东海,邹浴宇,等.糖尿病患者白内障术后黄斑区视网膜厚度和血-房水屏障改变[J]. 眼科新进展,2006,26(8):599-601. SUN Qian, LIAO Donghai, ZOU Yuyu, et al. Macular thickness change and blood- aqueous barrier disorders after cataract surgery in diabetic patients[J]. Recent Adv Ophthalmol, 2006, 26(8):599-601.
[8] Huang D, Swanson E A, Lin C P, et al. Optical Coherence tomography[J]. Science, 1991, 22(5035):1178-1181.
[9] Hee M R, Izatt J A, Swanson E A, et al. Optical coherene tomography of the human retina[J]. Arch-Ophthamol, 1995, 113(3):325-332.
[10] Shimura M, Nakazawa T, Yasuda K, et al. Diclofenac prevents an early event of macular thickening after cataract surgery in patients with diabetes[J]. J Ocul Pharmacol Ther, 2007, 23(3):284-291.
[11] Pearson P A, Comstock T L, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial[J]. Ophthalmology, 2011, 118(8):1580-1587.
[12] Kensaku M, Kanjuro M, Shiroaki S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema afer small incision cataract surgery[J]. Jpn J Ophthamol, 2000, 44(1):58-67.
[13] Maia O O Jr, Takahashi B S, Costa R A, et al. Combined laser and intravitreal triamcinolone for proliferative diabetic retinopathy and macular edema one-year results of a randomized clinical trial[J]. Am J Ophthalmol, 2009, 147(2):291-297.
[14] 高雯,廖荣丰.非甾体类抗炎药对白内障术后黄斑水肿的作用[J]. 安徽医科大学学报,2013,48(1):38-42. GAO Wen, LIAO Rongfeng. Non-steroidal anti-inflammatory drugs for the prevention of macular edema after cataract surgery[J]. Acta Anhui Med University, 2013, 48(1):38-42.
[1] 王新萌,姬俊雅,于浩南,付鸿臣,王翔,郑泽坤,李艳,钟莹莹. 急性闭角型青光眼超声乳化联合房角分离术后屈光预测准确性分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 74-79.
[2] 赵娟,焦万珍,赵博军. UWFSS-OCTA检测糖尿病视网膜病变微循环的变化[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 80-86.
[3] 朱明琼,李征,刘茹,田涛,彭婧利,吕倩怡,谭华霞. 基于OCT/OCTA的AI筛查系统在抗VEGF治疗糖尿病性黄斑水肿患者效果评价中的应用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 68-73.
[4] 孙庆祝,沈健,陈星,吴雁冰,曾论. 代谢指标在预测糖尿病性黄斑水肿患者雷珠单抗疗效中的作用[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 74-81.
[5] 朱云龙,王平,高萌. 误诊为中浆及视网膜炎的后巩膜炎1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 99-105.
[6] 李世强,马燕,王家伟. 光学相干断层扫描血管成像在全身疾病中的临床应用研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 127-134.
[7] 高琳,何金梅,杨明祎. 糖尿病视网膜病变患者血清Sestrin2和NADPH氧化酶2水平与眼底病变的相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 113-117.
[8] 黄旗,邓旭雯,王佩佩,陈烨群,古学军. 基于EyeSi手术模拟器评估眼科医师白内障手术水平[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 83-88.
[9] 丁术梁,王超凡,刘建亮. 眼内液检测指导精准治疗急性视网膜坏死1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 114-117.
[10] 黄娇,彭昌福. 甲状腺相关性眼病活动性客观评价的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 171-178.
[11] 辛梦,纪芳,代春华,张靖,刘澍. 医用透明质酸钠与平衡盐溶液在微创玻璃体手术中对眼表保护的影响[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 58-65.
[12] 沈嘉琪,李潇飒,毕燕龙,张敬法. 人工智能在DME筛查、诊断和预后中的应用[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 153-159.
[13] 鲍莹,刘志高,姜鹏飞,崔文轩,郑晓霞,杨梦瑶,司明威,王玉,王红. 康柏西普治疗糖尿病合并CRVO-ME高反射点的临床观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 55-60.
[14] 常威威,焦万珍,崔艳艳,赵杰,刘兆强,赵博军. 糖尿病性黄斑缺血的研究进展[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 130-136.
[15] 周静琳,李金香,曾琦. 577 nm阈值下微脉冲激光联合抗VEGF药物治疗难治性糖尿病性黄斑水肿的疗效观察[J]. 山东大学耳鼻喉眼学报, 2024, 38(2): 18-25.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!